These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
242 related articles for article (PubMed ID: 25496852)
1. MicroRNAs associated with initiation and progression of colonic polyp: a feasibility study. Aslam MI; Hussein S; West K; Singh B; Jameson JS; Pringle JH Int J Surg; 2015 Jan; 13():272-279. PubMed ID: 25496852 [TBL] [Abstract][Full Text] [Related]
2. Identification of microRNA-135b in stool as a potential noninvasive biomarker for colorectal cancer and adenoma. Wu CW; Ng SC; Dong Y; Tian L; Ng SS; Leung WW; Law WT; Yau TO; Chan FK; Sung JJ; Yu J Clin Cancer Res; 2014 Jun; 20(11):2994-3002. PubMed ID: 24691020 [TBL] [Abstract][Full Text] [Related]
3. MicroRNA Signatures of Colonic Polyps on Screening and Histology. Tsikitis VL; Potter A; Mori M; Buckmeier JA; Preece CR; Harrington CA; Bartley AN; Bhattacharyya AK; Hamilton SR; Lance MP; Thompson PA Cancer Prev Res (Phila); 2016 Dec; 9(12):942-949. PubMed ID: 27658891 [TBL] [Abstract][Full Text] [Related]
4. Relationship between Proença MA; Biselli JM; Succi M; Severino FE; Berardinelli GN; Caetano A; Reis RM; Hughes DJ; Silva AE World J Gastroenterol; 2018 Dec; 24(47):5351-5365. PubMed ID: 30598580 [TBL] [Abstract][Full Text] [Related]
5. miRNA expression in colon polyps provides evidence for a multihit model of colon cancer. Oberg AL; French AJ; Sarver AL; Subramanian S; Morlan BW; Riska SM; Borralho PM; Cunningham JM; Boardman LA; Wang L; Smyrk TC; Asmann Y; Steer CJ; Thibodeau SN PLoS One; 2011; 6(6):e20465. PubMed ID: 21694772 [TBL] [Abstract][Full Text] [Related]
6. Diagnostic Potential of Cell-Free and Exosomal MicroRNAs in the Identification of Patients with High-Risk Colorectal Adenomas. Uratani R; Toiyama Y; Kitajima T; Kawamura M; Hiro J; Kobayashi M; Tanaka K; Inoue Y; Mohri Y; Mori T; Kato T; Goel A; Kusunoki M PLoS One; 2016; 11(10):e0160722. PubMed ID: 27760147 [TBL] [Abstract][Full Text] [Related]
7. Comparison of microsatellite instability, CpG island methylation phenotype, BRAF and KRAS status in serrated polyps and traditional adenomas indicates separate pathways to distinct colorectal carcinoma end points. O'Brien MJ; Yang S; Mack C; Xu H; Huang CS; Mulcahy E; Amorosino M; Farraye FA Am J Surg Pathol; 2006 Dec; 30(12):1491-501. PubMed ID: 17122504 [TBL] [Abstract][Full Text] [Related]
8. Investigation of miRNA dysregulation and association with immune cell profile during malignant transformation of colorectal cells. Ng L; Li X; Wan TM; Iyer D; Sin RW; Lo OS; Foo DC; Law WL Eur J Surg Oncol; 2022 Jan; 48(1):245-252. PubMed ID: 34620510 [TBL] [Abstract][Full Text] [Related]
9. APC gene is modulated by hsa-miR-135b-5p in both diffuse and intestinal gastric cancer subtypes. Magalhães L; Quintana LG; Lopes DCF; Vidal AF; Pereira AL; D'Araujo Pinto LC; de Jesus Viana Pinheiro J; Khayat AS; Goulart LR; Burbano R; de Assumpção PP; Ribeiro-Dos-Santos  BMC Cancer; 2018 Oct; 18(1):1055. PubMed ID: 30376837 [TBL] [Abstract][Full Text] [Related]
10. Altered miR-21, miRNA-148a Expression in Relation to KRAS Mutation Status as Indicator of Adenoma-Carcinoma Transitional Pattern in Colorectal Adenoma and Carcinoma Lesions. Igder S; Mohammadiasl J; Mokarram P Biochem Genet; 2019 Dec; 57(6):767-780. PubMed ID: 30997628 [TBL] [Abstract][Full Text] [Related]
11. MicroRNA profiles in colorectal carcinomas, adenomas and normal colonic mucosa: variations in miRNA expression and disease progression. Slattery ML; Herrick JS; Pellatt DF; Stevens JR; Mullany LE; Wolff E; Hoffman MD; Samowitz WS; Wolff RK Carcinogenesis; 2016 Mar; 37(3):245-261. PubMed ID: 26740022 [TBL] [Abstract][Full Text] [Related]
12. MicroRNA-31 expression in relation to BRAF mutation, CpG island methylation and colorectal continuum in serrated lesions. Ito M; Mitsuhashi K; Igarashi H; Nosho K; Naito T; Yoshii S; Takahashi H; Fujita M; Sukawa Y; Yamamoto E; Takahashi T; Adachi Y; Nojima M; Sasaki Y; Tokino T; Baba Y; Maruyama R; Suzuki H; Imai K; Yamamoto H; Shinomura Y Int J Cancer; 2014 Dec; 135(11):2507-15. PubMed ID: 24752710 [TBL] [Abstract][Full Text] [Related]
14. MTUS1 and its targeting miRNAs in colorectal carcinoma: significant associations. Ozcan O; Kara M; Yumrutas O; Bozgeyik E; Bozgeyik I; Celik OI Tumour Biol; 2016 May; 37(5):6637-45. PubMed ID: 26643896 [TBL] [Abstract][Full Text] [Related]
15. Regulation of microRNA-1288 in colorectal cancer: altered expression and its clinicopathological significance. Gopalan V; Pillai S; Ebrahimi F; Salajegheh A; Lam TC; Le TK; Langsford N; Ho YH; Smith RA; Lam AK Mol Carcinog; 2014 Feb; 53 Suppl 1():E36-44. PubMed ID: 24009195 [TBL] [Abstract][Full Text] [Related]
16. BRAF and KRAS mutations in colorectal hyperplastic polyps and serrated adenomas. Chan TL; Zhao W; Leung SY; Yuen ST; Cancer Res; 2003 Aug; 63(16):4878-81. PubMed ID: 12941809 [TBL] [Abstract][Full Text] [Related]
17. Identification of high-risk Dukes B colorectal cancer by microRNA expression profiling: a preliminary study. Aslam MI; Venkatesh J; Jameson JS; West K; Pringle JH; Singh B Colorectal Dis; 2015 Jul; 17(7):578-88. PubMed ID: 25557290 [TBL] [Abstract][Full Text] [Related]
18. The relationship between EZH2 expression and microRNA-31 in colorectal cancer and the role in evolution of the serrated pathway. Kurihara H; Maruyama R; Ishiguro K; Kanno S; Yamamoto I; Ishigami K; Mitsuhashi K; Igarashi H; Ito M; Tanuma T; Sukawa Y; Okita K; Hasegawa T; Imai K; Yamamoto H; Shinomura Y; Nosho K Oncotarget; 2016 Mar; 7(11):12704-17. PubMed ID: 26871294 [TBL] [Abstract][Full Text] [Related]
19. [Immunophenotypes and gene mutations in colorectal precancerous lesions and adenocarcinoma]. Huang WT; Qiu T; Ling Y; Shi SS; Guo L; Zheng B; Lü N; Ying JM Zhonghua Bing Li Xue Za Zhi; 2013 Oct; 42(10):655-9. PubMed ID: 24433726 [TBL] [Abstract][Full Text] [Related]
20. KRAS and BRAF mutations and MSI status in precursor lesions of colorectal cancer detected by colonoscopy. Yamane LS; Scapulatempo-Neto C; Alvarenga L; Oliveira CZ; Berardinelli GN; Almodova E; Cunha TR; Fava G; Colaiacovo W; Melani A; Fregnani JH; Reis RM; Guimarães DP Oncol Rep; 2014 Oct; 32(4):1419-26. PubMed ID: 25050586 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]